Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter prospective study of Pifubing Xueduwan for acne vulgaris
ChiCTR2100051680Phase 4Recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Oct 2021
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pifubing xuedu wan in acne vulgaris, sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Global Acne Grading System (GAGS) response rate. Started Oct 2021; status: recruiting.
02
Drugs
pifubing xuedu wan
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on ChiCTR2100051680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051680.